During the past decade, Oncology of Northshore conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oncology of Northshore" are "Breast Cancer" (1 trials), "KEAP1 Gene Mutation" (1 trials), "NFE2L2 Gene Mutation" (1 trials), "NRF2 Gene Mutation" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Oncology of Northshore" in a lesser frequency.

Most popular intervention types in "Oncology of Northshore" are "Drug" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole Tablets" (1 trials), "Carboplatin Chemotherapy" (1 trials), "Dexamethasone 4 mg" (1 trials), "Exemestane Tablets" (1 trials) and "Folic acid 400 -1000 μg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology of Northshore" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oncology of Northshore". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncology of Northshore, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncology of Northshore, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".